Comparative Study of the Genetic Barriers and Pathways towards Resistance of Selective Inhibitors of Hepatitis C Virus Replication

Hepatitis C virus (HCV) inhibitors include direct-acting antivirals (DAAs) such as NS3 serine protease inhibitors, nucleoside and nonnucleoside polymerase inhibitors, and host-targeting antivirals (HTAs) such as cyclophilin inhibitors that have been developed in recent years. Drug-resistant HCV vari...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Delang, Leen, Vliegen, Inge, Froeyen, Mathy, Neyts, Johan
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2011
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165355/
https://ncbi.nlm.nih.gov/pubmed/21709100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00294-11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares